HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 212 filers reported holding HERBALIFE LTD in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,412,958 | -5.8% | 243,957 | -10.8% | 0.03% | -20.9% |
| Q2 2023 | $3,622,755 | +235756.4% | 273,622 | +186.8% | 0.04% | +79.2% |
| Q1 2023 | $1,536 | +357.1% | 95,403 | +322.7% | 0.02% | +242.9% |
| Q4 2022 | $336 | -100.0% | 22,571 | -56.0% | 0.01% | -68.2% |
| Q3 2022 | $1,021,000 | -81.2% | 51,352 | -80.7% | 0.02% | -84.6% |
| Q2 2022 | $5,443,000 | +65.5% | 266,146 | +145.7% | 0.14% | +85.7% |
| Q1 2022 | $3,288,000 | -29.8% | 108,312 | +2.5% | 0.08% | -18.1% |
| Q1 2021 | $4,685,000 | +47.3% | 105,624 | +59.5% | 0.09% | +4.4% |
| Q4 2020 | $3,181,000 | +2.7% | 66,205 | -0.3% | 0.09% | -33.3% |
| Q3 2020 | $3,096,000 | +71.0% | 66,371 | +64.9% | 0.14% | +50.0% |
| Q2 2020 | $1,811,000 | +86.5% | 40,258 | +20.9% | 0.09% | +3.4% |
| Q1 2020 | $971,000 | -40.5% | 33,302 | -2.8% | 0.09% | +19.2% |
| Q4 2019 | $1,633,000 | -6.5% | 34,255 | -25.8% | 0.07% | +21.7% |
| Q3 2019 | $1,747,000 | +14.5% | 46,156 | +29.4% | 0.06% | +39.5% |
| Q2 2019 | $1,526,000 | -70.8% | 35,680 | -63.8% | 0.04% | -80.1% |
| Q1 2019 | $5,225,000 | +15.3% | 98,608 | +28.3% | 0.22% | +140.0% |
| Q4 2018 | $4,532,000 | -26.5% | 76,886 | -32.0% | 0.09% | -41.9% |
| Q3 2018 | $6,168,000 | +19.7% | 113,064 | +17.9% | 0.16% | -13.4% |
| Q2 2018 | $5,152,000 | +129.6% | 95,908 | +316.5% | 0.18% | +145.2% |
| Q1 2018 | $2,244,000 | +9.4% | 23,025 | -24.0% | 0.07% | +40.4% |
| Q4 2017 | $2,052,000 | +9.4% | 30,297 | +9.6% | 0.05% | +8.3% |
| Q3 2017 | $1,875,000 | -22.7% | 27,639 | -18.7% | 0.05% | -35.1% |
| Q2 2017 | $2,426,000 | +25.6% | 34,009 | +2.4% | 0.07% | +25.4% |
| Q1 2017 | $1,932,000 | +290.3% | 33,228 | +222.9% | 0.06% | +353.8% |
| Q4 2016 | $495,000 | -75.6% | 10,292 | -68.6% | 0.01% | -72.9% |
| Q3 2016 | $2,030,000 | +0.8% | 32,749 | -4.8% | 0.05% | +11.6% |
| Q2 2016 | $2,014,000 | +94.4% | 34,413 | +81.0% | 0.04% | +22.9% |
| Q3 2015 | $1,036,000 | +74.7% | 19,008 | +20.8% | 0.04% | +66.7% |
| Q4 2014 | $593,000 | -23.4% | 15,740 | -11.1% | 0.02% | -25.0% |
| Q3 2014 | $774,000 | +69.0% | 17,700 | +149.3% | 0.03% | +55.6% |
| Q2 2014 | $458,000 | -46.7% | 7,100 | -52.7% | 0.02% | -50.0% |
| Q1 2014 | $860,000 | – | 15,022 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
| Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
| Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
| Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
| WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
| CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
| Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
| JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
| 683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
| Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |